AtaiBeckley

AtaiBeckley Dividend Yield

Delisted·Sep 11, 2026

Dividend Yield of AtaiBeckley (ATAI) as of Oct 16, 2026.

Dividend Yield

-

Last updated:

Dividend Yield of AtaiBeckley is 2026 - . Dividend Yield of AtaiBeckley was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AtaiBeckley Stock analysis

What does AtaiBeckley do? AtaiBeckley Inc, headquartered in Berlin, Germany, operates as a clinical-stage biopharmaceutical company in the Health Care sector. The company, listed on 18 June 2021, focuses on developing innovative treatments for mental health disorders. With 119 employees, it is advancing several therapeutic candidates, including PCN-101 for treatment-resistant depression, RL-007 for cognitive impairment in schizophrenia, and DMX-1002 for opioid use disorder. The company's pipeline also features compounds targeting post-traumatic stress disorder and generalized anxiety disorder. AtaiBeckley is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AtaiBeckley stock

On Eulerpool you can find the complete historical development of Dividend Yield AtaiBeckley since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's AtaiBeckley historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — AtaiBeckley

All Key Metrics — AtaiBeckley